Skip to search.
 TSX Up 0.60% TSX Ventures Up 1.02%

Incyte Corporation (INCY)

-NasdaqGS
104.28 Up 1.32(1.28%) Jul 31, 4:00PM EDT
|After Hours : 104.28 0.00 (0.00%) Jul 31, 4:22PM EDT
Add to Portfolio
Prev Close:102.96
Open:104.26
Bid:80.00 x 300
Ask:111.00 x 100
1y Target Est:118.80
Beta:-0.04
Next Earnings Date: 4-Aug-15INCY Earnings announcement
Day's Range:102.72 - 105.24
52wk Range:43.86 - 121.70
Volume:1,001,300
Avg Vol (3m):961,530
Market Cap:18.67B
P/E (ttm):N/A
EPS (ttm):-0.19
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
INCYUp 1.28%18.67B
AMGNUp 2.85%134.27B
CELGDown 0.48%104.10B
RHHBYUp 0.17%245.91B

Key Statistics

Forward P/E (1 yr):119.86
P/S (ttm):31.73
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.27
Quarterly EPS Est (Jun-15) :-0.11
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):-5.46

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics primarily for oncology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback